Fig. 1From: Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II studyKaplan–Meier survival curve of all patients enrolled in the present study. a Overall survival (OS) curve; b progression-free survival (PFS) curveBack to article page